4//SEC Filing
SIDRANSKY DAVID 4
Accession 0001628280-21-020221
CIK 0000771856other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 3:39 PM ET
Size
8.7 KB
Accession
0001628280-21-020221
Insider Transaction Report
Form 4
SIDRANSKY DAVID
Director10% Owner
Transactions
- Tax Payment
Common Stock
2021-10-15$10.08/sh+2,629$26,500→ 762,272 total - Exercise/Conversion
Common Stock
2021-10-15$1.59/sh+16,667$26,501→ 764,901 total - Award
Option to purchase Common Stock
2021-10-15+16,667→ 0 totalExercise: $1.59Exp: 2021-11-01→ Common Stock (16,667 underlying)
Footnotes (2)
- [F1]Represents a "net exercise" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on October 15, 2021.
- [F2]The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively.
Documents
Issuer
CHAMPIONS ONCOLOGY, INC.
CIK 0000771856
Entity typeother
Related Parties
1- filerCIK 0001277161
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 3:39 PM ET
- Size
- 8.7 KB